SignPath Pharma Inc.
www.signpathpharma.comSignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
Read more
SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
Read more
Country
State
Utah
City (Headquarters)
Sandy
Industry
Employees
1-10
Founded
2006
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President , Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Director , Chairman of the Board of Directors , Co - Founder
Email ****** @****.comPhone (***) ****-****Founder
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
Reach decision makers at SignPath Pharma Inc.
Free credits every month!
SignPath Pharma Inc. FAQ
Sandy, United States
Biotechnology Research
